Research output per year
Research output per year
Personal profile
Education/Academic qualification
PhD, Doctor of Philosophy (PhD), Ben-Gurion University of the Negev
1 Oct 2017 → 1 Oct 2020
Award Date: 1 Oct 2020
Bachelor, Bachelor of Science (BSc) in Computer Science, Open University of Israel
1 Oct 2013 → 1 Oct 2016
Award Date: 1 Oct 2016
PhD, Medical Doctor (MD), Tel Aviv University
1 Oct 2005 → 1 Oct 2009
Award Date: 1 Jun 2010
Bachelor, Bachelor of Medical Sciences (B. Med. Sci), Tel Aviv University
1 Oct 2002 → 1 Oct 2005
Award Date: 1 Oct 2005
External positions
Post-Doctorate, Harvard University
1 Nov 2020 → 30 Oct 2021
Head of Epidemiology & Research, Clalit Health Services
1 Nov 2016 → …
Fingerprint
Dive into the research topics where Noam Barda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)
Canetti, M., Barda, N., Gilboa, M., Indenbaum, V., Mandelboim, M., Gonen, T., Asraf, K., Weiss-Ottolenghi, Y., Amit, S., Doolman, R., Mendelson, E., Harats, D., Freedman, L. S., Kreiss, Y., Lustig, Y. & Regev-Yochay, G., 1 Dec 2023, In: Nature Communications. 14, 1, 1593.Research output: Contribution to journal › Comment/debate
Open Access -
Chronic health conditions among long-term survivors of adolescent and young adult cancer: A comparison of outcomes in Israel and the United States
Hayek, S., Libresco, G., Barda, N., Chao, C., Xu, L., Cannavale, K. L., Izraeli, S. & Armenian, S. H., 1 Jun 2023, In: Cancer. 129, 11, p. 1763-1776 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study
Regev-Yochay, G., Lustig, Y., Joseph, G., Gilboa, M., Barda, N., Gens, I., Indenbaum, V., Halpern, O., Katz-Likvornik, S., Levin, T., Kanaaneh, Y., Asraf, K., Amit, S., Rubin, C., Ziv, A., Koren, R., Mandelboim, M., Tokayer, N. H., Meltzer, L., Doolman, R., & 3 others, 1 May 2023, In: The Lancet Microbe. 4, 5, p. e309-e318Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel
Gilboa, M., Gonen, T., Barda, N., Cohn, S., Indenbaum, V., Weiss-Ottolenghi, Y., Amit, S., Asraf, K., Joseph, G., Levin, T., Kanaaneh, Y., Aydenzon, A., Canetti, M., Freedman, L., Zuckerman, N., Mendelson, E., Doolman, R., Kreiss, Y., Regev-Yochay, G. & Lustig, Y., 23 May 2023, In: JAMA network open. 6, 5, p. e2314757Research output: Contribution to journal › Article › peer-review
Open Access -
Fluctuations in Serum Creatinine Levels during Hospitalization and Long-Term End-Stage Kidney Disease and Mortality
Efros, O., Beckerman, P., Basson, A. A., Cohen, R., Klang, E., Frenkel Nir, Y., Soffer, S., Barda, N. & Grossman, E., 3 Aug 2023, In: JAMA network open. 6, 8, p. E2326996Research output: Contribution to journal › Article › peer-review
Open Access -
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
Gonen, T., Barda, N., Asraf, K., Joseph, G., Weiss-Ottolenghi, Y., Doolman, R., Kreiss, Y., Lustig, Y. & Regev-Yochay, G., 5 Sep 2023, In: JAMA network open. 6, 9, p. e2332813Research output: Contribution to journal › Article › peer-review
-
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up
Barda, N., Lustig, Y., Indenbaum, V., Zibly, D., Joseph, G., Asraf, K., Weiss-Ottolenghi, Y., Amit, S., Kliker, L., Abd Elkader, B., Ben-Ami, E., Canetti, M., Koren, R., Katz-Likvornik, S., Halpern, O., Mendelson, E., Doolman, R., Harats, D., Kreiss, Y., Mandelboim, M., & 1 others, 1 Mar 2023, (Accepted/In press) In: Clinical Microbiology and Infection. 29, 7, p. 918-923 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Barda, N., Canetti, M., Gilboa, M., Asraf, K., Indenboim, V., Weiss-Ottolenghi, Y., Amit, S., Zubli, D., Doolman, R., Mendelson, E., Freedman, L. S., Kreiss, Y., Lustig, Y. & Regev-Yochay, G., 3 Apr 2023, In: Clinical Infectious Diseases. 76, 7, p. 1315-1317 3 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
The ups and downs of observational vaccine research
Barda, N., 10 Mar 2023, (Accepted/In press) In: The Lancet Infectious Diseases. 23, 7, p. 767-768 2 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
Utility of early colonoscopy for acute lower gastrointestinal bleeding: a retrospective cohort study
Lahat, A., Klang, E., Rahman, N., Halabi, N., Avidan, B. & Barda, N., 1 Jan 2023, In: Therapeutic Advances in Gastroenterology. 16Research output: Contribution to journal › Article › peer-review
Open Access
Thesis
-
Improving Cardiovascular Disease Prediction
Author: Barda, N., 2020Supervisor: Bachmat, E. (Supervisor) & Davidovitch, N. (Supervisor)
Student thesis: Doctoral Thesis
Press/Media
-
Studie zur Booster-Impfung: So wirksam schützt die dritte Dosis
2/11/21
1 item of Media coverage
Press/Media
-
Maßnahmen gegen die vierte Welle: Wie wirksam schützt die Booster-Impfung?
1/11/21
1 item of Media coverage
Press/Media
-
Booster vaccine dose effective in reducing severe covid-19-related outcomes: Lancet study
1/11/21
1 item of Media coverage
Press/Media
-
COVID-19 Vaccine Effectiveness Against the Delta Variant in Adolescents
1/11/21
1 item of Media coverage
Press/Media
-
Largest Real-World Study Of Third Dose Of COVID-19 Vaccine Effectiveness
30/10/21 → 31/10/21
2 items of Media coverage
Press/Media
-
Largest real-world study of third dose of COVID-19 vaccine effectiveness
29/10/21 → 30/10/21
2 items of Media coverage
Press/Media
-
Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents
22/10/21
1 item of Media coverage
Press/Media
-
-
Clalit Research Institute Publishes Updated Results on Coronavirus Vaccination Effectiveness in The New England Journal of Medicine
Noa Dagan, Noam Barda & Oren Miron
23/04/21
1 item of Media coverage
Press/Media